SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous hepatitis B virus (HBV)-specific T ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data ...

However, rate of sustained elimination is still very low. Basis of HBV persistence Both viral and host factors including host virus interactions contribute to persistence of HBV. Most subjects ...

Screening rates for hepatitis D virus are not ideal among individuals with hepatitis B virus, who also have a higher all-cause mortality rate.

Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms like stomach pain, dark urine, fatigue, fever, jaundice (yellowing ...

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and checkpoint-resistant cancers, and a subsidiary of Grifols, announced today ...

A viral hepatitis infection is an inflammation of the liver, resulting in liver damage. There are different types of hepatitis viruses, including hepatitis B (HBV) and hepatitis C (HCV), which are ...

The majority (63.4%) of patients with NMOSD born before Taiwan's universal vaccination program had resolved HBV infection. Hepatitis B virus (HBV) infection before the onset of neuromyelitis optica ...

Any person who might have a new sexual partner or use injection drugs is particularly recommended to get the hepatitis B ...